Mycobacterium tuberculosis complex (MTBC) infections are treated with combinations of antibiotics; however, these regimens not as efficacious against multidrug and extensively drug resistant MTBC. Phenotypic (growth-based) susceptibility testing on slow growing bacteria like MTBC requires many weeks to months complete, whereas sequencing-based approaches can predict resistance (DR) reduced turn...